National Health Investors (NHI) Depreciation & Amortization (CF) (2015 - 2026)

National Health Investors' Depreciation & Amortization (CF) history runs 12 years deep, the most recent figure standing at $23.7 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 23.67% year-over-year to $23.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.8 million (down 12.68% YoY) and the FY2025 annual result came in at $80.9 million, up 13.3% from the prior year.
• Depreciation & Amortization (CF) was $23.7 million for Q1 2026 at National Health Investors, up from $20.2 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $23.7 million in Q1 2026 and bottomed at $17.1 million in Q4 2023.
• A 5-year average of $18.5 million and a median of $17.7 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slipped 13.97% — and 2026, when it advanced 23.67%.
• National Health Investors' Depreciation & Amortization (CF) stood at $17.3 million in 2022, then retreated by 1.11% to $17.1 million in 2023, then grew by 9.17% to $18.7 million in 2024, then grew by 8.22% to $20.2 million in 2025, then gained by 17.19% to $23.7 million in 2026.
• Business Quant data shows NHI's Depreciation & Amortization (CF) at $23.7 million in Q1 2026, $20.2 million in Q3 2025, and $19.9 million in Q2 2025.